Kymera Therapeutics
KYMR
#2602
Rank
ยฃ4.81 B
Marketcap
ยฃ58.94
Share price
-2.52%
Change (1 day)
152.77%
Change (1 year)

Revenue for Kymera Therapeutics (KYMR)

Revenue in 2025 (TTM): ยฃ29.64 Million

According to Kymera Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ29.56 Million. a decrease over the revenue in the year 2024 that were of ยฃ37.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kymera Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 ยฃ29.11 M-22.38%
2024 ยฃ37.51 M-39.19%
2023 ยฃ61.68 M59.38%
2022 ยฃ38.7 M-28.26%
2021 ยฃ53.95 M116.1%
2020 ยฃ24.96 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA